Back to Stakeholders
Care Delivery & Psychedelic FacilitationClinical Care Delivery OrganizationsHealth Systems & Hospitals
Research, Drug Development & ManufacturingAcademic & Non-Profit Research
Research, Drug Development & ManufacturingAcademic & Non-Profit ResearchSpecialized Academic Departments and Institutes
Care Delivery & Psychedelic FacilitationClinical Care Delivery Organizations
Care Delivery & Psychedelic Facilitation
Research, Drug Development & Manufacturing

Centre Hospitalier St Anne

France
1 Trial

GHU Paris Psychiatrie et Neurosciences (the current form of historic Hôpital Sainte-Anne) is France's leading university psychiatric hospital, pioneering psychedelic research under Jean Delay from the 1930s and now leading a 2024 ANR-funded psilocybin RCT aimed at dissociating therapeutic effects from acute psychedelic experience in treatment-resistant depression.

Academic Research

0 papers

Published Papers

0

Trial Involvement

1

Distinct Focus Topics

0

Latest Publication

Unknown

Quick Facts

Type
Other
HQ
France
Website
Visit

Sponsored Trials

1
RecruitingNA

Study of the Neural Circuits Underlying the Negative Emotional Bias of Depressive Disorders and Their Response to Ketamine (EMOKET)

Start Date
Compounds
Esketamine